Investegate |Fusion Antibodies Announcements | Fusion Antibodies: Update on Board changes
Investegate announcements from Fusion Antibodies, Update on Board changes
Stay updated with breaking news from Richard Buick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Fusion Antibodies, Update on Board changes
Shares issued under employee share option scheme
Fusion is a Belfast based biotechnology company providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications. The Company's ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation. These services include antigen expression, antibody production, purification and sequencing, antibody humanisation using Fusion's proprietary CDRx TM platform and the production of antibody gene...